(lp0
S'Generex Announces Reverse Stock Split Business Wire  - Mar 14, 2017 MIRAMAR, Florida &amp; TORONTO----Generex Biotechnology Corporation  today announced a reverse stock split of its shares of common stock at a ratio of 1-for-1000.'
p1
aS"Here's What Matters Right Now For Generex Biotechnology Corporation  Insider Financial - Feb 24, 2017 Generex Biotechnology Corporation  rocketed from $0.004 a share to $0.015 between January 20 and January 25, as the company announced it had signed an LOI to acquire a controlling interest in an entity called Emmaus Life Sciences,&nbsp;..."
p2
aS'Deconstructing The Generex Biotechnology Corporation  Pivot Insider Financial - Feb 1, 2017 Between January 20 and January 25, Generex Biotechnology Corporation  ran up from around $0.0045 a share, to $0.012 a share - a more than 166% gain.'
p3
aS'A Look at Generex Biotechnology Corporation  MicroCap Daily - Jan 17, 2016 Generex Biotechnology Corporation  has continued to move lower in recent months continuing a trend that has lasted for years.'
p4
aS'Emmaus Life Sciences, Inc. Enters into Collaborative Agreement with Generex ... PR Newswire  - Jan 24, 2017 TORRANCE, Calif., Jan. 24, 2017 /PRNewswire/ -- Emmaus announced today that it has entered into a letter of intent  to establish a collaborative agreement with Generex Biotechnology Corporation . Emmaus will sell&nbsp;...'
p5
aS'Generex Biotechnology Corporation  Gets Severely Corrected HotStocked - Jan 29, 2016 Anyone who has been following the stock will notice the massive drop in cash and current assets that GNBT has suffered from in 2015.'
p6
aS'GENEREX BIOTECHNOLOGY CORPORATION  Files An 8-K Entry into a ... Market Exclusive - Mar 7, 2017 Generex Biotechnology Corporation is a development-stage company. The Company is engaged primarily in the research and development of drug delivery systems and technologies.'
p7
aS"Generex Biotechnology Corporation  Continues To Recover HotStocked - Sep 3, 2015 The recent change in sentiment was caused by the last couple of PRs published by the company. GNBT released an update on the status of their buccal insulin formulation enhancement project for the company's Oral-lyn buccal insulin spray, a white paper&nbsp;..."
p8
aS'Spotlight on Generex Biotechnology Corporation  MicroCap Daily - Nov 15, 2015 Generex Biotechnology Corporation  is one penny stock that has got Investors attention as it continues to trade moderate volume just below the $0.01 mark.'
p9
aS'A Waking Bull: Generex Biotechnology Corporation  MicroCap Daily - Apr 21, 2015 Generex Biotechnology Corporation  has seen a recent jump in volume as the stock moves over the $0.02 mark. The stock has been upward bound since hitting an all-time low of $0.0105 in January.'
p10
a.